CEO, The Cultivated B
Hamid Noori is an entrepreneur and investor and serves as the CEO of The Cultivated B, a German Biotechnology company, and its subsidiaries in Canada. He received his PhDs in mathematics and physics from Universities of Heidelberg and Kaiserslautern and was honored with Venia Legendi from the Medical Faculty Mannheim of Heidelberg University. In 2008, he moved to Princeton University and focused his research on multiscale problems in neurosciences. He subsequently worked as a group leader in the Central Institute of Mental Health and occupied visiting professorships at the Institut des Hautes Etudes Scientifiques and Courant Institute for Mathematical Sciences of New York University, where he works with the Abel-Prize winner Mikhael Gromov on singularities of geometric flows. He served in an associate professor equivalent position and the head of the independent research group Neuronal Convergence at the Max Planck Institute for Biological Cybernetics. He was accepted as a Feodor-Lynen fellow of the Alexander von Humboldt Foundation in 2016, as a fellow of the Heidelberg Academy of Sciences and Humanities in 2017, as an overseas fellow of the Royal Society for Medicine and a member of the American Academy of Neurology in 2018. He further is a research affiliate in the McGovern Institute at MIT, USA. He received the Manfred Fuchs award for his pioneering work on neurobiology and cybernetics in 2017. Dr Hamid Noori was further awarded with the Ursula M Händel animal welfare award of the German Science Foundation and the DGPPN (German Association for Psychiatry, Psychotherapy and Psychosomatics) award for excellence in research of psychiatric diseases in 2018 and the Fred Yates award of the Society for the Study of Addiction for Researcher of the Year in 2019. In 2021, he was nominated and accepted as a full member of Sigma Xi (MIT Chapter), a scientific Honor Society, with notable alumni such as Albert Einstein, Enrico Fermi and James Watson. His latest academic appointment was the deputy director of a Chinese Academy of Sciences institute in Shanghai. Throughout his academic career, Dr. Noori received generous research funding from various programs including the Horizon2020 program of the European Commission and has published numerous scientific articles in high-impact journals such as Nature Communications, Cell Reports, Trends in Neurosciences and Proceedings of the National Academy of Sciences that have attracted the attention of renown international press such as the New York Times Magazine, The Guardian, and Independent.